World's Best Scientists 2026 revealed!
VIEW LIST
Thomas P. Monath

Thomas P. Monath

Crozet BioPharma
United States

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 92 1014 922 549 490 250 23536
Medicine 94 10623 9973 5459 5043 260 25278

Thomas P. Monath publications per year

The chart shows the history of publications by Thomas P. Monath between 1970 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Thomas P. Monath published across 56 years, from 1970 to 2025, averaging 5.2 papers a year. Output peaked at 15 publications in 2002. 12 of the 290 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1970 to 2025. Vertical axis: number of publications, 0 to 15. Peak 15 publications in 2002. 1970: 3 publications 1971: 4 publications 1972: 1 publication 1973: 3 publications 1974: 5 publications 1975: 1 publication 1976: 0 publications 1977: 0 publications 1978: 3 publications 1979: 2 publications 1980: 10 publications 1981: 10 publications 1982: 5 publications 1983: 3 publications 1984: 5 publications 1985: 11 publications 1986: 9 publications 1987: 9 publications 1988: 7 publications 1989: 4 publications 1990: 4 publications 1991: 0 publications 1992: 1 publication 1993: 3 publications 1994: 4 publications 1995: 3 publications 1996: 5 publications 1997: 5 publications 1998: 6 publications 1999: 12 publications 2000: 5 publications 2001: 8 publications 2002: 15 publications 2003: 10 publications 2004: 10 publications 2005: 10 publications 2006: 9 publications 2007: 3 publications 2008: 2 publications 2009: 4 publications 2010: 2 publications 2011: 7 publications 2012: 2 publications 2013: 6 publications 2014: 1 publication 2015: 1 publication 2016: 3 publications 2017: 9 publications 2018: 3 publications 2019: 2 publications 2020: 6 publications 2021: 5 publications 2022: 8 publications 2023: 9 publications 2024: 3 publications 2025: 9 publications
1970 2025

290 publications in total across all disciplines

View publications per year as a table
Thomas P. Monath: publications per year, 1970 to 2025
Year Publications
1970 3
1971 4
1972 1
1973 3
1974 5
1975 1
1976 0
1977 0
1978 3
1979 2
1980 10
1981 10
1982 5
1983 3
1984 5
1985 11
1986 9
1987 9
1988 7
1989 4
1990 4
1991 0
1992 1
1993 3
1994 4
1995 3
1996 5
1997 5
1998 6
1999 12
2000 5
2001 8
2002 15
2003 10
2004 10
2005 10
2006 9
2007 3
2008 2
2009 4
2010 2
2011 7
2012 2
2013 6
2014 1
2015 1
2016 3
2017 9
2018 3
2019 2
2020 6
2021 5
2022 8
2023 9
2024 3
2025 9
Total 290
Download as CSV

Thomas P. Monath publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas P. Monath sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 242–251 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 250 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160 250
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Thomas P. Monath D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas P. Monath sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72 92
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2011 - Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)

Overview

Thomas P. Monath is affiliated with Crozet BioPharma in the United States and has contributed extensively to research in the field of medicine, with a focus on infectious diseases. Their work spans multiple specialized areas including infectious diseases, public health, epidemiology, molecular biology, and immunology.

Their research topics cover a range of subjects related to viral infections and outbreaks, with particular attention to viral infections and vectors, mosquito-borne diseases, SARS-CoV-2 and COVID-19 research, virology and viral diseases, and COVID-19 epidemiological and clinical research studies.

Among notable publication venues, Monath has frequently published in:

  • Vaccine
  • American Journal of Tropical Medicine and Hygiene
  • npj Vaccines
  • Viruses
  • The Journal of Infectious Diseases

Their collaboration network includes frequent coauthors such as:

  • Claire-Anne Siegrist
  • Peter G. Kremsner
  • Donata Medaglini
  • Tom H. M. Ottenhoff
  • Francesco Santoro

Monath's recent papers reflect their research interests and include:

  • "The Origin of COVID-19 and Why It Matters," 2020, American Journal of Tropical Medicine and Hygiene
  • "Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial," 2021, The Lancet
  • "A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus," 2020, The Journal of Infectious Diseases
  • "A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2," 2022, Emerging Microbes & Infections
  • "High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster," 2022, The Journal of Infectious Diseases

Throughout their career, Monath has produced a significant volume of work in infectious diseases, with a total of 87 publications in medicine-related fields. They have received recognition as a Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH) in 2011.

Best Publications

  • Dengue: the risk to developed and developing countries

    Thomas P. Monath

  • ICTV Virus Taxonomy Profile: Flaviviridae.

    Peter Simmonds;Paul Becher;Jens Bukh;Ernest A. Gould

  • Epidemic arboviral diseases: priorities for research and public health

    Annelies Wilder-Smith;Annelies Wilder-Smith;Duane J Gubler;Scott C Weaver;Thomas P Monath

  • Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses

    Thomas H. Ermak;Paul J. Giannasca;Richard Nichols;Gwendolyn A. Myers

  • Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.

    Pierre Michetti;Christianna Kreiss;Karen L. Kotloff;Nadine Porta

  • Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine

    J D Poland;C H Calisher;T P Monath;W G Downs

  • Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone

    Thomas P. Monath;Verne F. Newhouse;Graham E. Kemp;Henry W. Setzer

  • Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.

    F. Guirakhoo;R. Weltzin;T. J. Chambers;Z.-X. Zhang

  • Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

    F. Guirakhoo;K. Pugachev;Z. Zhang;G. Myers

  • Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

    F. Guirakhoo;J. Arroyo;K. V. Pugachev;C. Miller

  • Oral Immunization with Recombinant Helicobacter pylori Urease Induces Secretory IgA Antibodies and Protects Mice from Challenge with Helicobacter felis

    Lee Ck;Weltzin R;Thomas Wd;Kleanthous H

  • Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

    Stavros Sougioultzis;Lorraine Kyne;Denise Drudy;Sarah Keates

  • The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.

    Emily S Jentes;Gilles Poumerol;Mark D Gershman;David R Hill

  • Proposed revision to the taxonomy of the genus Pestivirus, family Flaviviridae.

    Donald B. Smith;Donald B. Smith;Gregor Meyers;Jens Bukh;Ernest A. Gould

  • Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

    Thomas P. Monath;Farshad Guirakhoo;Richard Nichols;Sutee Yoksan

  • Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

    Thomas P Monath;Karen McCarthy;Philip Bedford;Casey T Johnson

  • Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.

    J J Schlesinger;M W Brandriss;C B Cropp;T P Monath

  • ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy

    Juan Arroyo;Chuck Miller;John Catalan;Gwendolyn A. Myers

  • Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

    Farshad Guirakhoo;Scott Kitchener;Dennis Morrison;Remi Forrat

  • A live, attenuated recombinant West Nile virus vaccine

    Thomas P. Monath;Jian Liu;Niranjan Kanesa-Thasan;Gwendolyn A. Myers

  • Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis☆

    F. Guirakhoo;Z.-X. Zhang;T.J. Chambers;S. Delagrave

  • Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

    Stephen B. Kennedy;Fatorma Bolay;Mark Kieh;Greg Grandits

  • Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

    Juan Arroyo;Farshad Guirakhoo;Sabine Fenner;Zhen-Xi Zhang

  • Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.

    Karen L. Kotloff;Steven S. Wasserman;Genevieve A. Losonsky;William Thomas

Frequent Co-Authors

Dennis W. Trent
Dennis W. Trent The University of Texas Medical Branch at Galveston
Alan D.T. Barrett
Alan D.T. Barrett The University of Texas Medical Branch at Galveston
Richard J. Nichols
Richard J. Nichols University of Liverpool
Jean Lang
Jean Lang Sanofi (France)
Barry R. Miller
Barry R. Miller Centers for Disease Control and Prevention
Annelies Wilder-Smith
Annelies Wilder-Smith University of Bern
Sharon E. Frey
Sharon E. Frey Saint Louis University
Philip Bejon
Philip Bejon University of Oxford
John T. Roehrig
John T. Roehrig Centers for Disease Control and Prevention
J. Erin Staples
J. Erin Staples Centers for Disease Control and Prevention

External Links

Personal website of Thomas P. Monath

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Accelerated nursing programs offer a fast track into clinical roles, with several options known for their accessibility. Students can consider the easiest absn programs to get into to quickly gain a Bachelor of Science in Nursing and begin working in patient care.

Licensed Practical Nurse (LPN) programs also provide a gateway into healthcare with programs that emphasize straightforward admission processes. Discovering easy admission lpn programs can help students start their nursing careers sooner with foundational skills in patient support and monitoring.

For advanced clinical roles, nurse practitioner degrees offer expanded responsibilities. Identifying which nurse practitioner program is easiest may assist applicants seeking programs that balance quality education with manageable admissions criteria.

Mental health is another critical area within immunology-related healthcare fields. Those interested can explore the top online pmhnp programs to find respected programs that offer strong clinical placement rates, crucial for hands-on experience in psychiatric mental health nursing.

Best Scientists Citing Thomas P. Monath

Alan D.T. Barrett

Alan D.T. Barrett

The University of Texas Medical Branch at Galveston

Publications: 82

Scott C. Weaver

Scott C. Weaver

The University of Texas Medical Branch at Galveston

Publications: 67

Annelies Wilder-Smith

Annelies Wilder-Smith

University of Bern

Publications: 67

Michael S. Diamond

Michael S. Diamond

Washington University in St. Louis

Publications: 57

Duane J. Gubler

Duane J. Gubler

Duke NUS Graduate Medical School

Publications: 57

Robert B. Tesh

Robert B. Tesh

The University of Texas Medical Branch at Galveston

Publications: 51

Ichiro Kurane

Ichiro Kurane

National Institutes of Health

Publications: 47

John T. Roehrig

John T. Roehrig

Centers for Disease Control and Prevention

Publications: 44

Thomas W. Scott

Thomas W. Scott

University of California, Davis

Publications: 43

Edward C. Holmes

Edward C. Holmes

University of Sydney

Publications: 42

Jean Lang

Jean Lang

Sanofi (France)

Publications: 39

Richard M. Kinney

Richard M. Kinney

Centers for Disease Control and Prevention

Publications: 39

Nicholas Komar

Nicholas Komar

Centers for Disease Control and Prevention

Publications: 39

Amelia P. A. Travassos da Rosa

Amelia P. A. Travassos da Rosa

The University of Texas Medical Branch at Galveston

Publications: 38

Stephen S. Whitehead

Stephen S. Whitehead

National Institute of Allergy and Infectious Diseases

Publications: 37

Roy A. Hall

Roy A. Hall

University of Queensland

Publications: 37

Trending Scientists

Jiantie Xu

Jiantie Xu

South China University of Technology

Wanchai Maleewong

Wanchai Maleewong

Khon Kaen University

Vicente J. Iragui

Vicente J. Iragui

University of California, San Diego

Audrey de Nazelle

Audrey de Nazelle

Imperial College London

Richard D. Miller

Richard D. Miller

University of Kansas

Somchart Soponronnarit

Somchart Soponronnarit

King Mongkut's University of Technology Thonburi

Jia Wang

Jia Wang

AT&T (United States)

Supeng Leng

Supeng Leng

University of Electronic Science and Technology of China

Bo Cheng

Bo Cheng

Beijing University of Posts and Telecommunications

Wu Lei

Wu Lei

Nanjing University of Science and Technology

Jim J. Lin

Jim J. Lin

National Taiwan University

Oscar A. Carretero

Oscar A. Carretero

Henry Ford Hospital

Robert N. Weinreb

Robert N. Weinreb

University of California, San Diego

Kjetil Hindar

Kjetil Hindar

Norwegian Institute for Nature Research

Vonda J. Cummings

Vonda J. Cummings

National Institute of Water and Atmospheric Research

Gregg G. Van Ryzin

Gregg G. Van Ryzin

Rutgers, The State University of New Jersey

Related Immunology Rankings & Guides

2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference

2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference
2027 Best Medical Transcription Courses Online

2027 Best Medical Transcription Courses Online
2027 Best ABSN Programs - Accelerated BSN Programs in Georgia: Online & Campus

2027 Best ABSN Programs - Accelerated BSN Programs in Georgia: Online & Campus
2027 Best LPN Programs in Georgia – Accredited Online LPN Programs

2027 Best LPN Programs in Georgia – Accredited Online LPN Programs
2027 Best LPN Programs in Florida – Accredited Online LPN Programs

2027 Best LPN Programs in Florida – Accredited Online LPN Programs
2027 Best Medical Assistant to LPN Programs Online

2027 Best Medical Assistant to LPN Programs Online
2027 Best LPN Programs in Utah – Accredited Online LPN Programs

2027 Best LPN Programs in Utah – Accredited Online LPN Programs
2027 Best 6-Month LPN to RN Programs Online

2027 Best 6-Month LPN to RN Programs Online
2027 Best Accelerated Online Bachelor's in Health Sciences Programs

2027 Best Accelerated Online Bachelor's in Health Sciences Programs
2027 Best MRI Technician Programs

2027 Best MRI Technician Programs
2027 Best 12-Month FNP Programs (Online & Campus)

2027 Best 12-Month FNP Programs (Online & Campus)
2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs

2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs
2027 Best Accelerated Medical Assistant to RN Online Bridge Programs

2027 Best Accelerated Medical Assistant to RN Online Bridge Programs
2027 Best ADN Nursing Programs in Texas: Online & Campus

2027 Best ADN Nursing Programs in Texas: Online & Campus
2027 Best Accelerated Online Nurse Executive Leadership MSN Programs

2027 Best Accelerated Online Nurse Executive Leadership MSN Programs
2027 Best Master’s in Dietetics Programs

2027 Best Master’s in Dietetics Programs
2027 Best ABSN Programs - List of Accelerated BSN Programs in Washington: Online & Campus

2027 Best ABSN Programs - List of Accelerated BSN Programs in Washington: Online & Campus
2027 Best Accelerated BSN to PhD Online Bridge Programs

2027 Best Accelerated BSN to PhD Online Bridge Programs
2027 Best HBCU Nursing Programs

2027 Best HBCU Nursing Programs
2027 Best LVN Programs in California – Accredited Online LVN Programs

2027 Best LVN Programs in California – Accredited Online LVN Programs
2027 Best Direct-Entry NP Programs for Non-Nurses

2027 Best Direct-Entry NP Programs for Non-Nurses

Recently Published Articles

2027 What Can You Do with a Social Media Master's Degree? Careers, Salaries & Growth

2027 What Can You Do with a Social Media Master's Degree? Careers, Salaries & Growth
2027 How Many Hours Per Week Do Online BCBA Programs Require

2027 How Many Hours Per Week Do Online BCBA Programs Require
2027 How to Become a Special Education Assistant: Education, Salary, and Job Outlook

2027 How to Become a Special Education Assistant: Education, Salary, and Job Outlook
2027 Cheapest and Shortest Online Occupational Therapy Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Occupational Therapy Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Best Online Information Technology Courses

2027 Best Online Information Technology Courses
2027 Best Fashion Merchandising Degrees for Working Adults

2027 Best Fashion Merchandising Degrees for Working Adults
2027 Best Online Behavioral Health Leadership Degrees for Jobs

2027 Best Online Behavioral Health Leadership Degrees for Jobs
2027 Quick-to-Learn Trade Jobs That Pay Well

2027 Quick-to-Learn Trade Jobs That Pay Well
2027 AI Master's Degrees in California: Best Options

2027 AI Master's Degrees in California: Best Options
2027 Military-Friendly Online Physical Therapy Assistant Degree Programs: Benefits, Accreditation, and Career Outcomes

2027 Military-Friendly Online Physical Therapy Assistant Degree Programs: Benefits, Accreditation, and Career Outcomes
2027 Highest Paying Careers With a Computer Science Bachelor's Degree

2027 Highest Paying Careers With a Computer Science Bachelor's Degree
2027 How to Become an Electrician in New Jersey

2027 How to Become an Electrician in New Jersey
2027 PharmD vs. PhD vs. Master of Science in Pharmaceutical Sciences: Which Degree Should You Pursue?

2027 PharmD vs. PhD vs. Master of Science in Pharmaceutical Sciences: Which Degree Should You Pursue?
2027 LICSW vs. LCSW vs. LISW: Explaining the Difference in Social Work Licensure

2027 LICSW vs. LCSW vs. LISW: Explaining the Difference in Social Work Licensure
2027 What Prerequisites Do You Need for a Human Services Master's Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for a Human Services Master's Degree? Entry Requirements, Credits & Eligibility Rules
2027 Health Informatics Concentrations With the Strongest Employer Demand

2027 Health Informatics Concentrations With the Strongest Employer Demand
2027 MBA vs. Master's in Counselor Education: Which Drives Better Career Outcomes

2027 MBA vs. Master's in Counselor Education: Which Drives Better Career Outcomes
2027 How to Become a Mental Health Counselor in Corpus Christi, TX: Education Requirements & Certification

2027 How to Become a Mental Health Counselor in Corpus Christi, TX: Education Requirements & Certification
2027 How to Become an Elementary School Teacher in Minnesota: Requirements & Certification

2027 How to Become an Elementary School Teacher in Minnesota: Requirements & Certification
2027 How to Become a Biostatistician: Education, Salary, and Job Outlook

2027 How to Become a Biostatistician: Education, Salary, and Job Outlook
2027 Best Value Online Health Informatics Master's Degrees: Affordable Accredited Programs with the Highest ROI

2027 Best Value Online Health Informatics Master's Degrees: Affordable Accredited Programs with the Highest ROI